The most common side effects of Ozempic are gastrointestinal: nausea, vomiting, diarrhea, stomach pain, and constipation. These affect a significant portion of users, especially during the first weeks of treatment and when doses increase. Most are mild to moderate and improve over time, but Ozempic also carries rarer, more serious risks that are worth understanding before you start or while you’re on it.
Why Ozempic Causes Stomach Problems
Ozempic (semaglutide) works by mimicking a hormone called GLP-1 that your body naturally releases after eating. This hormone acts on several targets at once: it signals the pancreas to release insulin, tells the brain’s satiety centers that you’re full, and slows down how fast your stomach empties food into the small intestine. That last effect, delayed gastric emptying, is the main reason so many users experience nausea, bloating, and vomiting. Food sits in the stomach longer than it normally would, creating that uncomfortable “too full” feeling even after small meals.
Common Side Effects and When They Peak
Nausea is the side effect most people notice first. It tends to be worst during dose increases, which happen roughly every four weeks as your prescriber gradually raises the amount. Vomiting, diarrhea, constipation, and abdominal pain round out the most frequently reported issues. For many people, these symptoms ease as the body adjusts to each new dose level.
Other common but less talked-about effects include fatigue, headache, and decreased appetite (which is partly the intended effect). Some people report changes in taste, heartburn, or excess gas. These generally don’t require medical treatment and tend to resolve on their own.
Reducing Nausea and GI Discomfort
Because delayed gastric emptying is behind most of the stomach trouble, strategies that help your stomach process food more comfortably can make a real difference. Eating slowly, choosing smaller meals, and avoiding high-fat or greasy foods all reduce the burden on a stomach that’s emptying more slowly than usual. One practical tip: stop eating at the first sensation of fullness rather than finishing what’s on your plate. Your usual portion sizes may be too much while on this medication.
Avoiding lying flat right after meals also helps, as does staying hydrated through small, frequent sips rather than drinking large amounts of water at once. Large fluid volumes can add to that overly full feeling just as much as food does.
Gallbladder Problems
Gallstones are a recognized risk with Ozempic, likely related to rapid weight loss rather than the drug itself. In clinical trials for weight management, gallstones were reported in 1.6% of patients on Ozempic compared to 0.7% on placebo. Symptoms to watch for include sudden, intense pain in the upper right abdomen, pain between the shoulder blades, or nausea that’s noticeably different from your usual GI side effects. Gallbladder issues sometimes require surgery, so new or severe abdominal pain is worth getting checked promptly.
Pancreatitis Risk
Acute pancreatitis, an inflammation of the pancreas that causes severe abdominal pain, has been reported in people taking GLP-1 drugs. It’s listed as a warning on the label, and prescribers monitor for it. However, a meta-analysis pooling data from multiple semaglutide trials found no statistically increased risk compared to placebo, with an odds ratio of 0.7. That means pancreatitis in people on semaglutide was actually numerically less common than in those taking a placebo, though the numbers were too small to draw firm conclusions either way. The key symptom is severe, persistent abdominal pain that may radiate to the back, often accompanied by vomiting. If that happens, it’s an emergency regardless of whether it’s pancreatitis or something else.
Thyroid Tumor Warning
Ozempic carries the FDA’s most serious warning label, a boxed warning, related to thyroid tumors. In animal studies, semaglutide caused tumors in thyroid C-cells, including a type called medullary thyroid carcinoma (MTC). Whether this happens in humans is unknown, and the relevance of the rodent findings hasn’t been determined. As a precaution, Ozempic is completely off-limits for anyone with a personal or family history of MTC or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Signs that would warrant evaluation include a lump or mass in the neck, difficulty swallowing, shortness of breath, or persistent hoarseness.
Eye Complications in People With Diabetes
If you’re taking Ozempic for type 2 diabetes and already have diabetic retinopathy, there’s an important nuance. A major clinical trial called SUSTAIN-6 found that semaglutide was associated with a higher rate of retinopathy complications, including bleeding inside the eye and decreased vision, with a hazard ratio of 1.76. This likely relates to how quickly blood sugar levels drop rather than a direct toxic effect on the eyes. Rapid improvement in blood sugar control can temporarily worsen existing eye disease. A Cleveland Clinic review noted that patients without pre-existing retinopathy taking GLP-1 drugs did not show worsening eye health. If you have diabetic eye disease, your eye doctor should be part of the conversation before you start.
Severe GI Reactions and Gastroparesis
In January 2025, the FDA updated Ozempic’s label to include a new warning about severe gastrointestinal adverse reactions. In clinical trials, severe GI events occurred in 0.4% to 0.8% of patients on Ozempic, compared to 0% on placebo. The label now states that Ozempic is not recommended for people with severe gastroparesis, a condition where the stomach already empties too slowly on its own. For people with milder stomach motility issues, the added slowing effect from the drug can tip things into uncomfortable or even dangerous territory.
Surgery and Anesthesia Concerns
Also added to the label in January 2025 is a warning about pulmonary aspiration during general anesthesia or deep sedation. Because Ozempic slows gastric emptying, some patients have had food remaining in their stomachs despite following standard fasting instructions before surgery. If stomach contents are inhaled into the lungs during anesthesia, it can cause a serious complication. There isn’t yet enough data to give specific guidance on how long to fast or whether to pause the medication before a procedure. The FDA has required a postmarketing study to answer exactly those questions. In the meantime, if you have any planned surgery or procedure involving sedation, let your surgical team know you’re on Ozempic so they can plan accordingly.
Less Common but Reported Effects
Some users report hair thinning, which is typically related to rapid weight loss and calorie reduction rather than a direct drug effect. Others notice increased heart rate, a known class effect of GLP-1 drugs that’s generally modest (a few beats per minute on average). Injection site reactions like redness, itching, or a small bump at the injection site also occur but tend to be mild. Serious allergic reactions are rare and listed as a contraindication for anyone who has had one previously.